STAT1 and non-small cell lung carcinoma: Similarly, in non-small cell lung cancer (NSCLC), downregulation of BIN1 inhibits ferroptosis via the G3BP1/STAT1/GSH pathway, which impairs CD8+ T cell function and promotes immune evasion (72).